Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy
Niclas E. Bengtsson(University of Washington), Jeffrey S. Chamberlain(University of Washington)
Cited by 383
Related Papers
Systemic delivery of genes to striated muscles using adeno-associated viral vectors
|Nature Medicine|2004|611
High levels of AAV vector integration into CRISPR-induced DNA breaks
|Nature Communications|2019|430
MULTIPLEX PCR FOR THE DIAGNOSIS OF DUCHENNE MUSCULAR DYSTROPHY
|Elsevier eBooks|1990|227
Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy
|Science Translational Medicine|2023|68